Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


ENANTA PHARMA   FYE=9 (September)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date9/30/20209/30/20199/30/20189/30/20179/30/20169/30/20159/30/20149/30/20139/30/20129/30/2011
Revenue----------------41.7141.88
Royalties122.47205.20191.6337.8157.6934.080.00------
Milestone payments----15.0065.0030.00125.0040.0026.00----
Revenue-Other--------0.581.807.746.05----
Total Revenues122.47205.20206.63102.8188.27160.8847.7432.0541.7141.88
Research and development136.76142.2194.8657.4540.4623.1918.7416.8415.1211.55
General and Administrative27.3626.2523.4420.7516.9713.5410.026.185.305.04
Total Operating Expenses164.11168.46118.3078.2057.4336.7328.7623.0220.4216.58
Income (Loss) from operations(41.64)36.7488.3324.6130.84124.1518.999.0321.2925.30
Interest expense----------0.010.020.03--3.16
Interest income6.478.824.852.491.690.970.470.250.120.08
Other income (expense), net------------------0.36
Change in fair value of warrant liability0.15--(0.06)(0.16)0.030.35(0.17)0.38(0.01)(0.69)
Therapeutic tax credit------------------0.75
Gain on embedded derivative------------------0.67
Total other income (expense), net6.628.824.79--1.721.310.280.600.11(1.99)
Income (loss) before income tax(35.02)45.5693.1226.9532.56125.4619.279.6321.4023.31
Income tax benefit1.15(0.83)21.179.2410.8946.46(15.17)------
Net Income (loss)(36.17)46.3871.9617.7121.6778.9934.449.6321.4023.31
Accretion of redeemable convertible preferred stock to redemption value--------------2.535.375.45
Net income attributable to participating securities--------------13.6714.6616.29
Net Income (loss) attributable to common stockholders(36.17)46.3871.9617.7121.6778.9934.44(6.57)1.371.57
Net income (loss) per share attributable to common stockholders :Basic(1.81)2.373.740.931.144.231.88(0.67)1.261.40
Net income (loss) per share attributable to common stockholders :Diluted(1.81)2.213.480.911.134.091.80(0.67)1.131.32
Weighted average common shares outstanding:Basic19.9419.5819.2619.0718.9318.6718.369.791.091.12
Weighted average common shares outstanding:Diluted19.9420.9720.6519.4119.2219.3019.199.792.471.86